LBT Innovations raises capital and generates sales leads in the US
19 June 2019 LBT Innovations Limited (ASX:LBT) chief executive officer Brent Barnes updates Proactive Investors on developments to forge ahead with product sales of its unique APAS Independence technology. The ground-breaking medical technology company has also raised $5…
Read MoreAustralian Biotechnology “REALITIES” : From the Laboratory to the Marketplace
12 June 2019 Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited,…
Read MoreNew Business Growth Fund to Create Jobs
7 June 2019 The Andrews Labor Government will establish a $250 million Victorian Business Growth Fund for small and medium enterprises to help them access capital and create jobs to grow the Victorian economy. Treasurer Tim Pallas today…
Read MoreSCHOTT AG to acquire Australian microfluidic expert MINIFAB
5 June 2019 Customers to benefit from complementary portfolio of top quality polymer and glass solutions for breakthrough diagnostics applications SCHOTT AG, a leading international technology group in the areas of specialty glass and glass-ceramics, has entered into…
Read MoreProactive Investors interviews CEO Sam Cobb on recent placement
5 June 2019 We are pleased to share the recent video recording of CEO, Sam Cobb in discussion with Proactive Investors. Sam provided further insight into the successful completion of a $5 million Placement announced last week, and…
Read MoreLBT $5M Oversubscribed Private Placement
5 June 2019 I’m pleased to announce today the successful capital raise of ~$5 million through a private placement. The Company welcomes the new institutional investors to the register and this capital injection to the business is positive…
Read MorePotential Cancer Treatment Discovery – SVI
5 June 19 We are pleased to announce that a study undertaken by SVI researchers Associate Professor Andrew Deans and Dr Julienne O’Rourke, in collaboration with the Children’s Medical Research Institute (CMRI) in Sydney, has identified not one,…
Read MoreFunding Vital Medical Research – Monash Vision Group
Monash Vision Group has received one of the ten $1M MRFF Frontiers grants to commercialise our BMI technologies. This is very exciting as it gives us a 20-40% chance of $100M to $50M Stage 2 funding and the…
Read More
